LoginSignup
Johnson&Johnson logo

Johnson&Johnson

Stock
Stock
ISIN: US4781601046
Ticker: JNJ
US4781601046
JNJ

Price

Price

Historical dividends and forecast

All dividend data

Johnson&Johnson has so far distributed $4.91 in 2024. The next dividend will be paid on 05.03.2025

$1.449

CHART BY

Frequently asked questions

What is Johnson&Johnson's market capitalization?

The market capitalization of Johnson&Johnson is $347.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Johnson&Johnson's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Johnson&Johnson is 23.88. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Johnson&Johnson?

Johnson&Johnson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.05. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Johnson&Johnson's stock?

Currently, 24 analysts cover Johnson&Johnson's stock, with a consensus target price of $176.21. Analyst ratings provide insights into the stock's expected performance.

What is Johnson&Johnson's revenue over the trailing twelve months?

Over the trailing twelve months, Johnson&Johnson reported a revenue of $87.69B.

What is the EBITDA for Johnson&Johnson?

Johnson&Johnson's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $28.86B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Johnson&Johnson?

Johnson&Johnson has a free cash flow of $20.75B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Johnson&Johnson have, and what sector and industry does it belong to?

Johnson&Johnson employs approximately 131,900 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Johnson&Johnson's shares?

The free float of Johnson&Johnson is 2.40B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$347.83B
EPS (TTM) 
$6.05
Free Float 
2.40B
P/E ratio (TTM) 
23.88
Revenue (TTM) 
$87.69B
EBITDA (TTM) 
$28.86B
Free Cashflow (TTM) 
$20.75B

Pricing

1D span
$142.75$145.46
52W span
$143.00$168.83

Analyst Ratings

The price target is $176.21 and the stock is covered by 24 analysts.

Buy

11

Hold

13

Sell

0

Information

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Employees
131,900
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
US4781601046
Primary Ticker
JNJ

Knockouts

Join the conversation
Sign upLogin